8-KEarnings & ResultsExhibits & Filings

IDEXX LABORATORIES INC /DE 8-K Report, Financial Results (May 1, 2019)

Filed May 1, 2019For Securities:IDXX

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K on May 1, 2019, to report its financial results for the quarter ended March 31, 2019. The key information is contained within the furnished press release (Exhibit 99.1), which is not considered "filed" under SEC regulations but provides important operational and financial data for investors. This filing primarily serves as a notification vehicle for the release of quarterly earnings. Investors should refer to the content of the press release for specific details on revenue, earnings per share, and any forward-looking guidance or strategic updates provided by the company. The CFO's signature confirms the accuracy of the submitted information.

Key Highlights

  • 1IDEXX Laboratories announced its first-quarter financial results for the period ending March 31, 2019.
  • 2The results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3The filing is made under Item 2.02 (Results of Operations and Financial Condition).
  • 4The furnished information is not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability for this specific disclosure.
  • 5The press release likely contains detailed financial performance metrics, including revenue and earnings.
  • 6Brian P. McKeon, Executive Vice President, Chief Financial Officer and Treasurer, signed the report.
  • 7This 8-K acts as an official record of the company's Q1 2019 earnings announcement.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce and furnish IDEXX Laboratories' financial results for the first quarter ended March 31, 2019, through an accompanying press release.

The detailed financial results are located in the press release titled 'IDEXX Laboratories Announces First Quarter Results,' which is furnished as Exhibit 99.1 to this 8-K filing. Investors should consult this exhibit for specific figures.

No, the information furnished under Item 2.02, including the press release, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This means the company has limited liability for this specific disclosure, although it is still an important announcement of results.

The 8-K filing was signed by Brian P. McKeon, who holds the positions of Executive Vice President, Chief Financial Officer, and Treasurer for IDEXX Laboratories, Inc.